Literature DB >> 29754237

CRISPR-Cas9-Mediated Genome Editing and Transcriptional Control in Yarrowia lipolytica.

Cory Schwartz1, Ian Wheeldon2.   

Abstract

The discovery and adaptation of RNA-guided nucleases has resulted in the rapid development of efficient, scalable, and easily accessible synthetic biology tools for targeted genome editing and transcriptional control. In these systems, for example CRISPR-Cas9 from Streptococcus pyogenes, a protein with nuclease activity is targeted to a specific nucleotide sequence by a short RNA molecule, whereupon binding it cleaves the targeted nucleotide strand. To extend this genome-editing ability to the industrially important oleaginous yeast Yarrowia lipolytica, we developed a set of easily usable and effective CRISPR-Cas9 episomal vectors. In this protocols chapter, we first present a method by which arbitrary protein-coding genes can be disrupted via indel formation after CRISPR-Cas9 targeting. A second method demonstrates how the same CRISPR-Cas9 system can be used to induce markerless gene cassette integration into the genome by inducing homologous recombination after DNA cleavage by Cas9. Finally, we describe how a catalytically inactive form of Cas9 fused to a transcriptional repressor can be used to control transcription of native genes in Y. lipolytica. The CRISPR-Cas9 tools and strategies described here greatly increase the types of genome editing and transcriptional control that can be achieved in Y. lipolytica, and promise to facilitate more advanced engineering of this important oleaginous host.

Entities:  

Keywords:  Bioprocessing; CRISPR interference; CRISPR-Cas9; Genome editing; Metabolic engineering; Synthetic biology; Yarrowia lipolytica

Mesh:

Substances:

Year:  2018        PMID: 29754237     DOI: 10.1007/978-1-4939-7795-6_18

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  1 in total

Review 1.  Advancing metabolic engineering of Yarrowia lipolytica using the CRISPR/Cas system.

Authors:  Tian-Qiong Shi; He Huang; Eduard J Kerkhoven; Xiao-Jun Ji
Journal:  Appl Microbiol Biotechnol       Date:  2018-09-21       Impact factor: 4.813

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.